BSE - Delayed Quote INR
Wockhardt Limited (WOCKPHARMA.BO)
1,396.35
-70.70
(-4.82%)
At close: April 25 at 3:52:58 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-898,100
2,190,000
1,530,000
4,130,000
-2,870,000
Investing Cash Flow
13,710,500
-1,370,000
-1,250,000
-2,010,000
14,700,000
Financing Cash Flow
-6,427,900
3,340,000
-3,150,000
-710,000
-11,710,000
End Cash Position
8,349,800
5,050,000
900,000
3,700,000
2,320,000
Capital Expenditure
-1,590,100
-2,160,000
-2,090,000
-2,120,000
-1,660,000
Issuance of Capital Stock
100
4,680,000
--
7,480,000
--
Issuance of Debt
5,124,400
5,490,000
4,090,000
16,340,000
4,100,000
Repayment of Debt
-8,085,100
-4,060,000
-4,060,000
-20,880,000
-9,550,000
Repurchase of Capital Stock
--
--
--
--
-3,540,000
Free Cash Flow
-2,488,200
30,000
-560,000
2,010,000
-4,530,000
3/31/2021 - 4/18/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
JAGSNPHARM.BO Jagsonpal Pharmaceuticals Limited
243.55
+1.82%
LVZPF Livzon Pharmaceutical Group Inc.
3.4300
0.00%
SEQUENT.NS Sequent Scientific Limited
148.12
-3.84%
BIOGY BioGaia AB (publ)
10.81
0.00%
APLLTD.BO Alembic Pharmaceuticals Limited
875.45
-0.68%
SOLARA.BO Solara Active Pharma Sciences Limited
509.40
-4.60%
PSG.DE PharmaSGP Holding SE
23.60
-0.84%
SOLARA.NS Solara Active Pharma Sciences Limited
508.85
-4.74%
ASTRAZEN.NS AstraZeneca Pharma India Limited
8,725.00
-2.70%
GUFICBIO.NS Gufic Biosciences Limited
363.75
-5.40%